- Trials with a EudraCT protocol (54)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
54 result(s) found for: Tonometry.
Displaying page 1 of 3.
EudraCT Number: 2015-005314-29 | Sponsor Protocol Number: QTM/OMN-0115 | Start Date*: 2016-03-02 |
Sponsor Name:OMNIVISION GmbH | ||
Full Title: Randomized, open-label, two parallel group clinical trial, conducted under blinding evaluator conditions to compare the efficacy and tolerability of preservative-free formulation of Latanoprost 50µ... | ||
Medical condition: Open Angle Glaucoma or Ocular Hypertension | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2009-015824-27 | Sponsor Protocol Number: MeBN/06/NEB-CBP/001 | Start Date*: 2009-12-23 |
Sponsor Name:MENARINI Benelux NV/SA | ||
Full Title: The effects of Nebivolol/HCTZ on Central Arterial Pressure, a randomised double-blind cross-over trial | ||
Medical condition: Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001237-27 | Sponsor Protocol Number: ESR-14-10158 | Start Date*: 2016-09-01 |
Sponsor Name:Instituto Gallego de Medicina Vascular (IGAMEVAS S.L.) | ||
Full Title: A randomized, unicenter, parallel study of the effect of dapagliflozin on central blood pressure reduction compared to glimepiride in adult subjects with type 2 Diabetes Mellitus and inadequate gly... | ||
Medical condition: Type 2 Diabetes Mellitus | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002947-27 | Sponsor Protocol Number: SYL040012_IV | Start Date*: 2014-07-01 | |||||||||||
Sponsor Name:Sylentis S.A.U. | |||||||||||||
Full Title: A phase II, observer masked, active controlled study of SYL040012 for the treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension (SYLTAG) | |||||||||||||
Medical condition: Open angle glaucoma - intraocular pressure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002096-26 | Sponsor Protocol Number: MV-3-2017 | Start Date*: 2017-08-24 | ||||||||||||||||||||||||||
Sponsor Name:Universitetsklinik for Nyresygdomme og Blodtryksforhøjelse, Regionshospitalet Holstebro; Hospitalsenheden Vest | ||||||||||||||||||||||||||||
Full Title: Investigate the differences between treating Chronic Kidney Disease - Mineral and Bone Disorder with an iron-containing phosphate binder or a calcium-containing phosphate binder in dialysis patients. | ||||||||||||||||||||||||||||
Medical condition: Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD), especially bone metabolism and blood vessel calcification | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-000252-35 | Sponsor Protocol Number: DA-TCS-AD | Start Date*: 2020-07-09 | ||||||||||||||||
Sponsor Name:Lone Skov | ||||||||||||||||||
Full Title: The risk of an elevated intraocular pressure after treatment with topical corticosteroids in the periocular region | ||||||||||||||||||
Medical condition: Intraocular pressure in healthy individuals and in patients with atopic dermatitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001849-33 | Sponsor Protocol Number: SYL040012_III | Start Date*: 2012-04-09 | |||||||||||
Sponsor Name:Sylentis S.A.U. | |||||||||||||
Full Title: DOSE FINDING CLINICAL TRIAL WITH SYL040012 TO EVALUATE THE TOLERABILITY AND EFFECT ON INTRAOCULAR PRESSURE IN SUBJECTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA | |||||||||||||
Medical condition: Ocular Hypertension or Open-Angle Glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) ES (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005416-26 | Sponsor Protocol Number: ANSWER | Start Date*: 2014-06-06 |
Sponsor Name:Mario Negri Institute | ||
Full Title: A Prospective, Randomized, Open, Blinded Endpoint (PROBE), Clinical Trial to Assess The Renal and Humoral Effects of Sevelamer Carbonate in Patients with Chronic Kidney Disease and Residual Protein... | ||
Medical condition: Chronic Kidney Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-005170-25 | Sponsor Protocol Number: GNT-01-21 | Start Date*: 2022-02-10 | |||||||||||
Sponsor Name:Genetic S.p.A. | |||||||||||||
Full Title: PHASE III MULTICENTER RANDOMIZED TRIAL OF PRESERVATIVE FREE LATANOPROST 50µG/ML VS XALATAN IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION | |||||||||||||
Medical condition: Patients with Open-Angle Glaucoma or ocular hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001855-10 | Sponsor Protocol Number: SNAP1 | Start Date*: 2019-01-22 | |||||||||||
Sponsor Name:Department of Ophtalmology, Rigshospitalet-Glostrup | |||||||||||||
Full Title: Steroids and Non-steroidal Anti-inflammatory drugs in the Postoperative regime after trabeculectomy. An investigator-initiated randomized study (The SNAP study) | |||||||||||||
Medical condition: Medically uncontrolled glaucoma that requires filtration surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000328-85 | Sponsor Protocol Number: FINNHT1 | Start Date*: 2017-05-18 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Helsinki University Hospital, Obstetrics and Gynecology | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Randomized comparative trial between abrupt and tapered mode of discontinuation of longterm hormone therapy: Impact on endothelial function, recurrence of vasomotor symptoms and quality of life | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: We will assess the effects of hormone therapy termination on endothelial function using biophysical (flow-mediated dilation, peripheral artery tonometry) and biochemical markers. We will compare th... | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002630-39 | Sponsor Protocol Number: 3tcAZ | Start Date*: 2011-10-25 |
Sponsor Name:Oslo University Hospital Rikshospitalet | ||
Full Title: MICROVASCULAR RESISTANCE IN WOMEN WITH CHEST PAIN AND NO OR MINIMAL CORONARY ARTERY DISEASE | ||
Medical condition: Investigation of otherwise healthy women with chest pain without significant stenoses in their epicardial coronary arteries. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001267-11 | Sponsor Protocol Number: Jens05 | Start Date*: 2008-09-29 | |||||||||||
Sponsor Name:Department of Nephrology | |||||||||||||
Full Title: Saving residual kidney function among haemodialysis patients receiving irbesartan - a double blind randomised study | |||||||||||||
Medical condition: We want to investigate if an angiotensin II antagonist (irbesartan) has beneficial effects regarding residual kidney function and heart/vessels among haemodialysis patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003525-30 | Sponsor Protocol Number: COLCAD | Start Date*: 2022-01-06 | |||||||||||
Sponsor Name:Aarhus University Hospital, Steno Diabetes Center Aarhus | |||||||||||||
Full Title: Effect of colchicine on cardiovascular target organ damage in patients with type 2 diabetes - A randomized placebo-controlled trial | |||||||||||||
Medical condition: Type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002189-38 | Sponsor Protocol Number: 44945 | Start Date*: 2017-10-11 |
Sponsor Name:Erasmus Medical Center | ||
Full Title: OPTIMIZING PERIPHERAL CIRCULATION WITH VASODILATOR THERAPY IN CRITICALLY ILL PATIENTS WITH CIRCULATORY SHOCK: A PILOT STUDY | ||
Medical condition: Circulatory shock | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003689-24 | Sponsor Protocol Number: PAVC1012 | Start Date*: 2009-04-29 | |||||||||||
Sponsor Name:Moorfields Eye Hospital NHS Foundation Trust | |||||||||||||
Full Title: Lotemax in the treatment of chronic anterior uveitis: a pilot study | |||||||||||||
Medical condition: Chronic Anterior Uveitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000397-45 | Sponsor Protocol Number: OY060301 | Start Date*: 2005-06-02 |
Sponsor Name:Queen's Medical centre | ||
Full Title: Randomised Controlled Trial Of Intravitreal Triamcinolone In Patients With Diabetic Macular Oedema Refractory To Laser Treatment | ||
Medical condition: Diabetic macular oedema affecting vision and refractory to laser treatment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002060-17 | Sponsor Protocol Number: 2015/077/HP | Start Date*: 2015-08-21 | |||||||||||||||||||||
Sponsor Name:CHU - Hôpitaux de Rouen | |||||||||||||||||||||||
Full Title: Effect of pharmacological heart rate reduction on visco-elastic properties of the arterial wall - Impact of aging | |||||||||||||||||||||||
Medical condition: Healthy subjects between 25 and 65 years old | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023612-14 | Sponsor Protocol Number: N/A | Start Date*: 2013-03-08 | |||||||||||
Sponsor Name:Clinical Trials and Research Governance | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled pilot trial of irbesartan, doxycycline and a combination on markers of vascular dysfunction in the Marfan syndrome, using cardiovascular magnetic reso... | |||||||||||||
Medical condition: Marfan syndrome. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002095-10 | Sponsor Protocol Number: MV-2-2017 | Start Date*: 2017-09-13 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Universitetsklinik for Nyresygdomme og Blodtryksforhøjelse, Regionshospitalet Holstebro; Hospitalsenheden Vest | ||||||||||||||||||||||||||||||||||||||
Full Title: Investigate the differences between treating Chronic Kidney Disease - Mineral and Bone Disorder with an iron-containing phosphate binder or a calcium-containing phosphate binder in Chronic Kidney D... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD), especially bone metabolism and blood vessel calcification | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
